Cat Allergy (Disorder) Clinical Trial
Official title:
An Open-label, Multicentre Study Comparing the Biological Potency of the Native, Depigmented and Depigmented Polymerized Cat Epithelial Allergenic Extracts.
The primary objective of this clinical trial is to quantify the loss of in vivo biological potency of a depigmented polymerized (DPP) allergenic cat epithelial extract versus the native allergenic extract (N).
This is an open-label, non-randomized phase II clinical trial.
Three different concentrations of three different cat epithelial allergenic extracts,
together with a positive and negative control, using 10 mg/ml histamine dihydrochloride and
a glycerated phenol saline solution, respectively, will be tested in every subject on the
volar surface of the forearm.
;
Intervention Model: Single Group Assignment, Masking: Open Label